We repeated our analyses excluding families from the University of Michigan and Johns Hopkins Hospital, some of which were included in the initial report describing HOXB13 as a prostate cancer susceptibility gene (Ewing et al. 2012). This evidence concerns the gene HOXB13 and prostate cancer.